美研究发现：杏仁或可预防糖尿病和心脏病 http://news.sciencenet.cn/htmlnews/2010/12/242250.shtm Eating almonds could help prevent diabetes and heart disease, say scientists http://www.dailymail.co.uk/health/article-1342476/Eating-almonds-help-prevent-diabetes-heart-disease-say-scientists.html http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/edit_b.cgi Start A-Literature C-Literature B-list Filter Literature A-query: diabetes and heart disease C-query: almonds The B-list contains title words and phrases (terms) that appeared in both the A and the C literature. 4 articles appeared in both literatures and were not included in the process of computing the B-list but can be viewed here . The results of this search are saved under id # 14173 and can be accessed from the start page after you leave this session. There are 639 terms on the current B-list ( 170 are predicted to be relevant), which is shown ranked according to predicted relevance. The list can be further trimmed down using the filters listed in the left margin. To assess whether there appears to be a biologically significant relationship between the AB and BC literatures for specific B-terms, please select one or more B-terms and then click the button to view the corresponding AB and BC literatures. Use Ctrl to select multiple B-terms. job id # 14173 started Thu Dec 30 23:55:04 2010 Max_citations: 50000 Stoplist: /var/www/html/arrowsmith_uic/data/stopwords_pubmed Ngram_max: 3 14173 Search ARROWSMITH A A_query_raw: diabetes and heart diseaseThu Dec 30 23:55:25 2010 A query = diabetes and heart disease started Thu Dec 30 23:55:26 2010 A query resulted in 39927 titles 14173 Search ARROWSMITH C C_query_raw: almonds Thu Dec 30 23:55:44 2010 C: almonds 2253 A: pubmed_query_A 39927 AC: ( diabetes and heart disease ) AND ( almonds ) 4 C query = almonds started Thu Dec 30 23:55:46 2010 C query resulted in 2253 titles A AND C query resulted in 4 titles 4218 B-terms ready on Thu Dec 30 23:58:52 2010 Sem_filter: Chemicals Drugs 639 B-terms left after filter executed Fri Dec 31 00:17:17 2010 B-list on Fri Dec 31 00:25:16 2010 1 monounsaturated fat 2 statin 3 cholesterol lowering 4 monounsaturated 5 aquaporin 6 peroxisome proliferator activated 7 proliferator activated receptor 8 ldl particle 9 lipid risk 10 antioxidant status 11 ldl oxidation 12 hdl 13 antioxidant capacity 14 total antioxidant capacity 15 density lipoprotein cholesterol 16 plasma lipid 17 hypoglycemic 18 cox-2 19 effect aldose reductase 20 antioxidant vitamin 21 microsatellite dna 22 total antioxidant 23 lipoprotein cholesterol 24 ldl cholesterol 25 apolipoprotein e 26 apolipoprotein 27 ldl 28 glucosidase inhibitor 29 plant sterol 30 peroxisome proliferator 31 normal glucose 32 nitric oxide synthase 33 anthocyanin content 34 cyclooxygenase-2 35 lovastatin 36 inducible nitric oxide 37 glucosidase inhibitory 38 phytosterol 39 transfer protein 40 antioxidant activity 41 serum lipoprotein 42 proteasome 43 polyphenol 44 expression cyclooxygenase-2 45 streptozotocin 46 lipid transfer protein 47 blood lipid 48 oxidative damage mitochondrial 49 aldose reductase 50 hdl c 51 antioxidant defense 52 glycemic control lipid 53 lower ldl 54 angiotensin converting enzyme 55 basis function neural 56 glucosidase 57 proanthocyanidin 58 radical scavenging 59 flavonoid phenolic 60 oxidative damage 61 peroxynitrite 62 mapk 63 lipoprotein a 64 angiotensin 65 cyclooxygenase 66 urban rural 67 density lipoprotein 68 asparagine linked 69 igf i 70 lipoprotein 71 oxidative dna damage 72 anthocyanin 73 alpha glucosidase inhibitory 74 polyamine level 75 transfer protein gene 76 radical scavenging activity 77 free radical scavenging 78 antioxidant system 79 triacylglycerol 80 igf 81 mitochondrial dna 82 insulin secretion insulin 83 low density lipoprotein 84 hypoglycemic effect 85 antioxidant 86 abscisic acid 87 anti inflammatory effect 88 cdna 89 stem bark 90 oxygen radical 91 lipase 92 estrogen receptor beta 93 transcription factor 94 calmodulin 95 stress healthy 96 insulin action 97 antioxidant property 98 soy protein 99 linked n acetylglucosamine 100 c reactive protein 101 epic 102 bark 103 sulindac 104 cholesterol lipoprotein 105 homocysteine 106 converting enzyme 107 naproxen 108 induced oxidative 109 lipid insulin 110 linolenic acid 111 secretion insulin 112 diuretic 113 carotene 114 flavonoid 115 flavonol 116 enzyme linked 117 apolipoprotein b-100 118 lyase 119 phenolic 120 fat 121 alpha linolenic acid 122 triterpene 123 complementary alternative 124 insulin secretion 125 glycosidase 126 protein gene 127 epitope 128 lipase activity 129 tacrine 130 ubiquitin 131 glucose 132 hydroxyl radical 133 green tea 134 capsid protein 135 effect plasma lipid 136 rt 137 oxidative 138 urban 139 cholesterol 140 helicase 141 insulin 142 lipid peroxide 143 plasma cholesterol 144 phytochemical 145 lipid response 146 pth 147 beta lactamase 148 heavy metal 149 cholesterol low 150 antioxidant potential 151 soy 152 fatty acid 153 glucoside 154 carbohydrate 155 disease 21st century 156 atomic force 157 magnesium 158 reduce oxidative 159 erk 160 cell epitope 161 trace element 162 uk 163 antihyperlipidemic 164 creb 165 catechin 166 vitamin c e 167 pv 168 nitric oxide donor 169 plasma alpha tocopherol 170 san http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/show_sentences.cgi Start A-Literature C-Literature B-list Filter Literature AB literature B-term BC literature diabetes and heart disease statin almonds 1: Standard-dose statin therapy provides incremental clinical benefits in normocholesterolemic diabetic patients.2010 Add to clipboard 2: Statin s and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.2010 Add to clipboard 3: Clinical significance of mild lipid-lowering by statin s for prevention of cardiovascular disease in Japanese high-risk patients.2010 Add to clipboard 4: Modeling the 4D Study: statin s and cardiovascular outcomes in long-term hemodialysis patients with diabetes.2010 Add to clipboard 5: Efficacy and safety of statin s in the treatment of diabetic dyslipidemia.2010 Add to clipboard 6: Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).2010 Add to clipboard 7: Prevalence and overlap of different lipid abnormalities in statin -treated patients at high cardiovascular risk in clinical practice in Germany.2010 Add to clipboard 8: Long-Term Statin Therapy is Associated with Better Episodic Memory in Aged Familial Hypercholesterolemia Patients in Comparison with Population Controls.2010 Add to clipboard 9: HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.2010 Add to clipboard 10: The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome.2010 Add to clipboard 11: Statin Utilization in Nursing Home Patients after Cardiac Hospitalization.2010 Add to clipboard 12: Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.2010 Add to clipboard 13: 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines.2010 Add to clipboard 14: Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy.2010 Add to clipboard 15: Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials.2010 Add to clipboard 16: Benefits of statin therapy and compliance in high risk cardiovascular patients.2010 Add to clipboard 17: Effect of high dose statin therapy on platelet function; statin s reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.2009 Add to clipboard 18: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).2009 Add to clipboard 19: Should we treat all patients with coronary heart disease or the equivalent with statin s?2009 Add to clipboard 20: Effect of previous treatment with statin s on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.2009 Add to clipboard 21: 2009 Add to clipboard 22: N-3 polyunsaturated fatty acids and statin s in heart failure.2009 Add to clipboard 23: Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction.2009 Add to clipboard 24: Managing diabetic dyslipidemia: beyond statin therapy.2009 Add to clipboard 25: Prevalence of cardiovascular comorbidities and utilization of evidence-based treatment strategies among statin users in a Medicare and commercial health plan.2009 Add to clipboard 26: Cardiovascular disease in patients with renal disease: the role of statin s.2009 Add to clipboard 27: Managing statin myopathy.2009 Add to clipboard 28: Preoperative statin use and infection after cardiac surgery: a cohort study.2009 Add to clipboard 29: Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin 's advantage and the smoking paradox.2009 Add to clipboard 30: The role of statin s in the treatment of the metabolic syndrome.2009 Add to clipboard 31: Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statin s in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.2009 Add to clipboard 32: The statin s in prevention of coronary heart diseases in type 2 diabetics.2009 Add to clipboard 33: Congestive heart failure is associated with lipoprotein components in statin -treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).2009 Add to clipboard 34: Statin s do not decrease the risk for wet age-related macular degeneration.2009 Add to clipboard 35: Who does not need a statin : too late in end-stage renal disease or heart failure?2009 Add to clipboard 36: Optimizing the start time of statin therapy for patients with diabetes.2009 Add to clipboard 37: The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.2009 Add to clipboard 38: The gravity of JUPITER (Justification for the Use of Statin s in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).2009 Add to clipboard 39: Statin s, ACE inhibitors and ARBs in cardiovascular disease.2009 Add to clipboard 40: Impact of better adherence to statin agents in the primary prevention of coronary artery disease.2009 Add to clipboard 41: Reducing morbidity and mortality in high risk patients with statin s.2009 Add to clipboard 42: Lipid lowering versus pleiotropic effects of statin s on skin microvascular function in patients with dysglycaemia and coronary artery disease.2009 Add to clipboard 43: The gender differences in baseline characteristics and statin intervention among outpatients with coronary heart disease in China: the China Cholesterol Education Program.2009 Add to clipboard 44: Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results.2009 Add to clipboard 45: Statin s reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.2009 Add to clipboard 46: Statin s for secondary cardiovascular disease prevention for older primary care patients.2009 Add to clipboard 47: Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statin s in patients with coronary artery disease.2009 Add to clipboard 48: Role of statin s in diabetes complications.2009 Add to clipboard 49: Factors predicting cardiovascular events in statin -treated diabetic and non-diabetic patients with coronary atherosclerosis.2009 Add to clipboard 50: 2009 Add to clipboard 51: Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study.2009 Add to clipboard 52: Statin therapy and risk of developing type 2 diabetes: a meta-analysis.2009 Add to clipboard 53: Long-term use of statin s and risk of colorectal cancer: a population-based study.2009 Add to clipboard 54: Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statin s.2009 Add to clipboard 55: An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy.2009 Add to clipboard 56: Statin initiation by GPs in WA--a structured vignette study.2009 Add to clipboard 57: The effect of statin therapy on the progression of carotid artery stenosis in relation to stenosis severity.2009 Add to clipboard 58: Time for new indications for statin s?2009 Add to clipboard 59: 2009 Add to clipboard 60: Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events ).2009 Add to clipboard 61: Commentary to factors predicting cardiovascular events in statin -treated diabetic and non-diabetic patients with coronary atherosclerosis (1).2009 Add to clipboard 62: Statin Therapy Decreases Myocardial Function as Evaluated Via Strain Imaging.2009 Add to clipboard 63: 2009 Add to clipboard 64: Questioning thebeatificationof statin s.2008 Add to clipboard 65: Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe -statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.2008 Add to clipboard 66: High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.2008 Add to clipboard 67: Effect of statin s, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients or=65 years of age with heart failure and preserved left ventricular systolic function.2008 Add to clipboard 68: Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients.2008 Add to clipboard 69: The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.2008 Add to clipboard 70: Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?2008 Add to clipboard 71: Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?2008 Add to clipboard 72: Optimal management of combined dyslipidemia: what have we behind statin s monotherapy?2008 Add to clipboard 73: Statin therapy for stroke prevention.2008 Add to clipboard 74: 2008 Add to clipboard 75: Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.2008 Add to clipboard 76: Initiating statin s in the elderly: the evolving challenge.2008 Add to clipboard 77: Statin s in the spectrum of neurologic disease.2008 Add to clipboard 78: Clinical and public health assessment of benefits and risks of statin s in primary prevention of coronary events: resolved and unresolved issues.2008 Add to clipboard 79: Can cheap generic statin s achieve national cholesterol lowering targets?2008 Add to clipboard 80: Randomized clinical outcome trials of statin s in heart failure.2008 Add to clipboard 81: Cholesterol lowering is more important than pleiotropic effects of statin s for endothelial function in patients with dysglycaemia and coronary artery disease.2008 Add to clipboard 82: Statin therapy improves outcomes after valvular heart surgery.2008 Add to clipboard 83: Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statin s and 5-phosphodiesterase inhibitors.2008 Add to clipboard 84: Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.2008 Add to clipboard 85: Benefit of adding pioglitazone to successful statin therapy in nondiabetic patients with coronary artery disease.2008 Add to clipboard 86: Equity in the use of antithrombotic drugs, beta-blockers and statin s among Finnish coronary patients.2008 Add to clipboard 87: Statin s improve human coronary atherosclerotic plaque morphology.2008 Add to clipboard 88: SLCO1B1 variants and statin -induced myopathy--a genomewide study.2008 Add to clipboard 89: Do people with diabetes need statin s?2008 Add to clipboard 90: Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.2008 Add to clipboard 91: Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.2008 Add to clipboard 92: Who does not need a statin : too late in end-stage renal disease or heart failure?2008 Add to clipboard 93: Ptosis, diplopia and statin s: an association?2008 Add to clipboard 94: Impact of adherence to statin s on chronic heart failure in primary prevention.2008 Add to clipboard 95: Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery.2008 Add to clipboard 96: Effect of statin s alone versus statin s plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.2008 Add to clipboard 97: Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.2008 Add to clipboard 98: Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.2007 Add to clipboard 99: Degeneration of native and tissue prosthetic valve in aortic position: do statin s play an effective role in prevention?2007 Add to clipboard 100: Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation.2007 Add to clipboard 101: Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.2007 Add to clipboard 102: Case selection for statin s was similar in two Canadian provinces: BC and Ontario.2007 Add to clipboard 103: Ezetimibe added to statin therapy (EASY study) - an evaluation by Australian general practitioners.2007 Add to clipboard 104: Statin s prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities.2007 Add to clipboard 105: Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial ).2007 Add to clipboard 106: Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2.2007 Add to clipboard 107: Role of statin s for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus.2007 Add to clipboard 108: Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statin s versus not on statin s presenting with suspected acute coronary syndrome.2007 Add to clipboard 109: Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.2007 Add to clipboard 110: Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin .2007 Add to clipboard 111: Statin therapy for vascular failure.2007 Add to clipboard 112: Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin -treated patients with coronary artery disease.2007 Add to clipboard 113: Effect of pioglitazone and its combination with statin s in coronary artery disease patients with hyperinsulinemia.2007 Add to clipboard 114: Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective.2007 Add to clipboard 115: Patterns and predictors of statin use after coronary artery bypass graft surgery.2007 Add to clipboard 116: Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.2007 Add to clipboard 117: Statin use in Canadians: trends, determinants and persistence.2007 Add to clipboard 118: Residual risk in statin -treated patients: future therapeutic options.2007 Add to clipboard 119: A population-based analysis of statin utilization in British Columbia.2007 Add to clipboard 120: Statin s in hepatobiliary diseases: effects, indications and risks.2007 Add to clipboard 121: Effects of statin s beyond lipid lowering: potential for clinical benefits.2006 Add to clipboard 122: Effect of statin s on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis.2006 Add to clipboard 123: Statin /fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.2006 Add to clipboard 124: Statin s for high-risk patients without heart disease or high cholesterol.2006 Add to clipboard 125: Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.2006 Add to clipboard 126: Statin s associated with reduced mortality in patients admitted for congestive heart failure.2006 Add to clipboard 127: The broad-reaching power of statin s. Thesewonderdrugs offer an astounding range of benefits to treat--and prevent--heart disease.2006 Add to clipboard 128: Statin safety: an assessment using an administrative claims database.2006 Add to clipboard 129: Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statin s in the elderly.2006 Add to clipboard 130: Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.2006 Add to clipboard 131: Statin -associated pleiotropy: possible beneficial effects beyond cholesterol reduction.2006 Add to clipboard 132: Are statin s analogues of vitamin D?2006 Add to clipboard 133: Statin s: are any questions unanswered?2006 Add to clipboard 134: Statin s for diabetic cardiovascular complications.2006 Add to clipboard 135: The reduction of inflammatory biomarkers by statin , fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.2006 Add to clipboard 136: Niacin-ER /statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.2006 Add to clipboard 137: Statin s and the primary prevention of cardiovascular events.2006 Add to clipboard 138: Association between the dosage and duration of statin treatment with coronary collateral development.2006 Add to clipboard 139: High-dose statin s for diabetes.2006 Add to clipboard 140: 2006 Add to clipboard 141: Who should receive a statin these days? Lessons from recent clinical trials.2006 Add to clipboard 142: Does the metabolic syndrome help to select patients requiring high statin dose?2006 Add to clipboard 143: Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).2006 Add to clipboard 144: Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statin s.2006 Add to clipboard 145: Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statin s.2006 Add to clipboard 146: Factors associated with healthcare utilization costs for statin therapy--a pilot study in Hong Kong.2006 Add to clipboard 147: Statin therapy and risks for death and hospitalization in chronic heart failure.2006 Add to clipboard 148: 2006 Add to clipboard 149: Primary and secondary prevention of heart failure with statin s.2006 Add to clipboard 150: Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statin s Atorvastatin and Rosuvastatin (PULSAR).2006 Add to clipboard 151: Management of dyslipidemia with statin s in the patient with peripheral arterial disease.2006 Add to clipboard 152: High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.2006 Add to clipboard 153: Is atorvastatin superior to other statin s? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints.2006 Add to clipboard 154: Statin use and the risk of Alzheimer's disease: the MIRAGE study.2006 Add to clipboard 155: The influence of guidelines on the use of statin s: analysis of prescribing trends 1998-2002.2005 Add to clipboard 156: Statin s decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statin s for Risk Reduction in Surgery (StaRRS) study.2005 Add to clipboard 157: Peripheral arterial disease: a missed opportunity to administer statin s so as to reduce cardiac morbidity and mortality.2005 Add to clipboard 158: Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.2005 Add to clipboard 159: Do statin s influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?2005 Add to clipboard 160: Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?2005 Add to clipboard 161: Effects of switching statin s on lipid and apolipoprotein ratios in the MERCURY I study.2005 Add to clipboard 162: I've read that, because I have type 2 diabetes, I should take a statin even though my cholesterol levels are normal. Is this true?2005 Add to clipboard 163: Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.2005 Add to clipboard 164: Statin s and CVD prevention in the diabetic population: implications of the CARDS trial.2005 Add to clipboard 165: No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease.2005 Add to clipboard 166: Diabetes and progression of coronary calcium under the influence of statin therapy.2005 Add to clipboard 167: The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.2005 Add to clipboard 168: Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.2005 Add to clipboard 169: Statin use after acute myocardial infarction: a nationwide study in Denmark.2005 Add to clipboard 170: Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?2005 Add to clipboard 171: A case control study of age related macular degeneration and use of statin s.2005 Add to clipboard 172: Lipid management with statin s in type 2 diabetes mellitus.2005 Add to clipboard 173: Statin s and LDL-cholesterol lowering: an overview.2005 Add to clipboard 174: Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.2005 Add to clipboard 175: The past, present, and future of statin therapy.2005 Add to clipboard 176: A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.2005 Add to clipboard 177: Stroke prevention, blood cholesterol and statin s.2005 Add to clipboard 178: Drug Insight: statin s and stroke.2005 Add to clipboard 179: Nonlipid-lowering effects of statin s.2005 Add to clipboard 180: Reducing residual risk for patients on statin therapy: the potential role of combination therapy.2005 Add to clipboard 181: Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).2005 Add to clipboard 182: 2005 Add to clipboard 183: The benefits of statin therapy--what questions remain?2005 Add to clipboard 184: New and emerging data from clinical trials of statin s.2004 Add to clipboard 185: Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery.2004 Add to clipboard 186: Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile.2004 Add to clipboard 187: Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.2004 Add to clipboard 188: Undertreatment and overtreatment with statin s: the Oslo Health Study 2000-2001.2004 Add to clipboard 189: Effects of switching statin s on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.2004 Add to clipboard 190: Meta-analysis of large randomized controlled trials to evaluate the impact of statin s on cardiovascular outcomes.2004 Add to clipboard 191: Lipid-lowering therapy with statin s in high-risk elderly patients: the treatment-risk paradox.2004 Add to clipboard 192: Association of dyslipidemia and effects of statin s on nonmacrovascular diseases.2004 Add to clipboard 193: Statin therapy is associated with lower mortality among patients with severe heart failure.2004 Add to clipboard 194: Statin s in atherosclerosis: lipid-lowering agents with antioxidant capabilities.2004 Add to clipboard 195: Quantifying the effect of applying the NCEP ATP III criteria in a managed care population treated with statin therapy.2004 Add to clipboard 196: The cardioprotective effects of statin s.2004 Add to clipboard 197: Cardiovascular outcomes among participants with diabetes in the recent large statin trials.2004 Add to clipboard 198: Impact of angiotensin-converting enzyme inhibitors and statin s on survival in idiopathic pulmonary fibrosis.2004 Add to clipboard 199: Statin s for all patients with type 2 diabetes: not so soon.2004 Add to clipboard 200: Should angiotensin II receptor blockers and statin s be combined?2004 Add to clipboard 201: A combination of statin s and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.2004 Add to clipboard 202: Statin -induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.2004 Add to clipboard 203: 2004 Add to clipboard 204: The potential role of statin s in contrast nephropathy.2004 Add to clipboard 205: Statin s: can the new generation make an impression?2004 Add to clipboard 206: Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.2004 Add to clipboard 207: Level of awareness of on-treatment patients about prescribed statin s.2004 Add to clipboard 208: Frequency of statin use in type 2 diabetics having macrovascular disease- at a Tertiary Care Hospital of Karachi.2004 Add to clipboard 209: Statin s and diabetes.2004 Add to clipboard 210: Expanding indications of statin s; implications of the Heart Protection Study.2003 Add to clipboard 211: Efficacy of rosuvastatin compared with other statin s at selected starting doses in hypercholesterolemic patients and in special population groups.2003 Add to clipboard 212: 2003 Add to clipboard 213: Effect of statin s on mortality and cardiovascular events in elderly high-risk persons.2003 Add to clipboard 214: Statin s. Evidence of effectiveness in older patients.2003 Add to clipboard 215: Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes.2003 Add to clipboard 216: Statin s, super -statin s and cholesterol absorption inhibitors.2003 Add to clipboard 217: Elderly diabetics with peripheral arterial disease and no coronary artery disease have a higher incidence of new coronary events than elderly nondiabetics with peripheral arterial disease and prior myocardial infarction treated with statin s and with no lipid-lowering drug.2003 Add to clipboard 218: The impact of statin treatment on diabetic patients.2003 Add to clipboard 219: Potential nontraditional applications of statin s.2003 Add to clipboard 220: Lipid and nonlipid benefits of statin s.2003 Add to clipboard 221: Effects of statin s on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study).2003 Add to clipboard 222: Statin s: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statin s.2003 Add to clipboard 223: Hypercholesterolemia. The evidence supports use of statin s.2003 Add to clipboard 224: Statin s indispensable for people with diabetes.2003 Add to clipboard 225: Anti-inflammatory effects of statin s in patients with aortic stenosis.2003 Add to clipboard 226: Statin s and renal function in patients with diabetes mellitus.2003 Add to clipboard 227: Benefits of statin treatment in cardiac syndrome-X1.2003 Add to clipboard 228: Cardiovascular disease with diabetes or the metabolic syndrome: should statin s or fibrates be first line lipid therapy?2003 Add to clipboard 229: Statin s for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductase.2003 Add to clipboard 230: The impact of reimbursement criteria on the appropriateness of 'statin ' prescribing.2003 Add to clipboard 231: Do Singapore patients require lower doses of statin s? The SGH Lipid Clinic experience.2003 Add to clipboard 232: 2003 Add to clipboard 233: Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes?2003 Add to clipboard 234: Management of dyslipidemias in the age of statin s.2003 Add to clipboard 235: Patients with acute coronary syndromes should received statin s.2002 Add to clipboard 236: Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy.2002 Add to clipboard 237: Statin -induced fibrotic nonspecific interstitial pneumonia.2002 Add to clipboard 238: High persistence of statin use in a Danish population: compliance study 1993-1998.2002 Add to clipboard 239: Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol or=125 mg/dl treated with statin s versus no lipid-lowering drug.2002 Add to clipboard 240: 2002 Add to clipboard 241: Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statin s.2002 Add to clipboard 242: The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.2002 Add to clipboard 243: Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.2002 Add to clipboard 244: Comparing the effects of five different statin s on the HDL subpopulation profiles of coronary heart disease patients.2002 Add to clipboard 245: Answering the unanswered questions: ongoing trials of statin s and antihypertensives in type 2 diabetes.2002 Add to clipboard 246: Getting more people on statin s.2002 Add to clipboard 247: Clinical significance of pleiotropic effects of statin s: lipid reduction and beyond.2002 Add to clipboard 248: Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol /=125 mg/dl treated with statin s.2002 Add to clipboard 249: 2002 Add to clipboard 250: 2002 Add to clipboard 251: Wider role seen forremarkable ;statin s. Study suggests that benefits extend even to those withnormalcholesterol levels.2002 Add to clipboard 252: Does pretreatment with statin s improve clinical outcome after stroke? A pilot case-referent study.2001 Add to clipboard 253: 2001 Add to clipboard 254: What do the statin trials tell us?2001 Add to clipboard 255: Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statin s.2001 Add to clipboard 256: What do the statin trials tell us?2001 Add to clipboard 257: Ongoing clinical trials of statin s.2001 Add to clipboard 258: Association of coronary risk factors and use of statin s with progression of mild valvular aortic stenosis in older persons.2001 Add to clipboard 259: Cost-effectiveness of prescribing statin s according to pharmaceutical benefits scheme criteria.2001 Add to clipboard 260: 2001 Add to clipboard 261: Cost-effectiveness of statin s.2000 Add to clipboard 262: 2000 Add to clipboard 263: Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.2000 Add to clipboard 264: Statin s: where are we now?2000 Add to clipboard 265: 2000 Add to clipboard 266: 1999 Add to clipboard 267: 1999 Add to clipboard 268: 1999 Add to clipboard 1: Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.2007 Add to clipboard 2: Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants.2005 Add to clipboard 3: Direct comparison of dietary portfolio vs statin on C-reactive protein.2005 Add to clipboard
标签: 化学、药物
